December 29, 2015 — Although using the radial artery as the access point for angioplasty has been linked to reduced bleeding compared to use of the femoral artery, only a small number of high-risk heart attack patients who undergo rescue angioplasty are treated by radial access, according to a study published in the Dec. 21 issue of the Journal of the American College of Cardiology: Cardiovascular Interventions.


Chicago EndoVascular Conference

The arterial track covers all aspects of arterial disease including a Critical limb ischemia, limb salvage, complex below-the-knee intervention, Crossing complex CTOs,  atherectomy, anti-restenosis therapies, Aortic aneurysm and dissection, carotid, renal and mesenteric disease.

Vascular Annual Meeting

The Society for Vascular Surgery 2016 Vascular Annual Meeting is a premier meeting for vascular surgeons, June 8-11, 2016 at Gaylord National Resort in National Harbor, Md. (located just outside Washington, D.C.).  The 2015 event attracted more than 2,700 attendees, including 1,590 vascular health professionals and 110 exhibiting companies occupying 180 booths. 

December 28, 2015 — National Cheng Kung University (NCKU) in Taiwan and Duke University School of Medicine are collaborating to develop a counter-pulsation left ventricular assist device (VAD), The device has been in development for about 10 years and is designed to be a bridge to help failing heart recover instead of a VAD to simply support the heart long enough to enable a transplant.


December 28, 2015 — Toshiba announced Dec. 21 it is considering selling off its healthcare division as part of its restructuring plans in the aftermath of its falsified financial reporting scandal from earlier this year. 

In February 2015, Toshiba revealed it had manipulated its financial figures for the past seven years to improve the image of its bottom line following the global economic downturn starting in 2008. In September Toshiba submitted amended financial reports from 2015 back to April 2009 to correct the misinformation on the previous reports. 

December 28, 2015 — The U.S. Food and Drug Administration (FDA) said Boston Scientific has started a Class I recall of its Chariot Guiding Sheath after receiving 14 complaints of the shaft of the device separating. This can cause small pieces to break off the device and enter the patient’s bloodstream. 

Leading cardiologist Valentin Fuster, M.D., Ph.D., has developed a free mobile application called “Circle of Health” to empower individuals around the globe to take action to comprehensively assess and enhance their daily overall heart health.

Patients who have had a stroke in the back of the brain are at greater risk of having another within two years if blood flow to the region is diminished, according to results of a multicenter study led by researchers at the University of Illinois at Chicago (UIC).


Statins are lifesaving medications — they have been shown to greatly reduce heart attack and other related events by more than 30 percent — yet patient compliance is a significant problem.[1] Studies estimate that up to 50 percent of patients with cardiovascular disease stop taking their statin medications as directed.[2]  Many do so because they experience statin induced myopathy, the onset of muscle aches, spasms and pain associated with statin therapy.


Trinity Biotech plc announced submission of its Meritas Point of Care Analyzer and Meritas cardiac troponin-I (cTnI) point-of-care assay for U.S. Food and Drug Administration (FDA) 510(k) clearance.

Subscribe Now